HRQOL in Prostate Cancer Patients Treated With Radiotherapy

Active, not recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2030

Conditions
Prostate Cancer
Interventions
RADIATION

radiotherapy

Radiotherapy is delivered with linear accelerators or cyberknife (external beam radiotherapy), or local irradiation with high dose rate brachytherapy (brachytherapy)

Trial Locations (1)

3015 GD

Radiotherapy, Erasmus MC Cancer Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

lead

Erasmus Medical Center

OTHER

NCT05645237 - HRQOL in Prostate Cancer Patients Treated With Radiotherapy | Biotech Hunter | Biotech Hunter